Hospital
Indiana University Health Jay, INC.
Indiana University Health Jay, INC. was paid $6.09M by Medicaid between Mar 2018 and Nov 2024, across 87 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.
33Billing provider infoINDIANA UNIVERSITY HEALTH JAY, INC.
PORTLAND, IN 47371
PORTLAND, IN 47371
33aNPI1801315692assigned 09/13/2017
33bProvider typeCritical Access Hospital
28Total paid$6.09M
24GClaims110,168
24DCodes billed87
24AFirst – last monthMar 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Indiana
Rank by total paid#8 of 26
Median peer was paid$4.16M
This provider vs. median1.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,139 | $477K | |
| 2019 | 13,753 | $621K | |
| 2020 | 10,801 | $492K | |
| 2021 | 19,271 | $1.03M | |
| 2022 | 22,006 | $1.25M | |
| 2023 | 17,599 | $1.17M | |
| 2024incomplete | 12,599 | $1.05M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 9,181 | 8,254 | $1.37M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 19% | 12,728 | 10,946 | $1.18M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 5,347 | 4,681 | $767K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 9.3% | 6,446 | 5,270 | $566K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.4% | 3,659 | 3,133 | $449K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 6.8% | 3,299 | 1,699 | $417K |
| 71045 | Radiologic examination, chest; single view | 3.5% | 1,651 | 1,421 | $212K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.2% | 2,165 | 1,922 | $133K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.6% | 1,446 | 1,028 | $100K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 1,618 | 1,419 | $94K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.5% | 1,622 | 1,392 | $91K |
| H0038 | Self-help/peer services, per 15 minutes | 1.2% | 546 | 302 | $72K |
75 more codes
| 36415 | Collection of venous blood by venipuncture | 1.0% | 15,610 | $62K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 706 | $54K |
| 80053 | Comprehensive metabolic panel | <1% | 8,273 | $47K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,048 | $43K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 550 | $37K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 519 | $35K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 86 | $30K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 868 | $28K |
| 80050 | General health panel | <1% | 238 | $28K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 240 | $25K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 537 | $19K |
| 87503 | <1% | 706 | $16K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,156 | $15K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 374 | $14K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 278 | $14K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 128 | $13K |
| 87428 | <1% | 452 | $13K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 132 | $13K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 150 | $11K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,494 | $9K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 58 | $9K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 424 | $7K |
| 84484 | <1% | 1,397 | $7K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 419 | $7K |
| 80061 | Lipid panel | <1% | 771 | $6K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 221 | $6K |
| 99221 | <1% | 15 | $6K | |
| 87276 | <1% | 418 | $5K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 43 | $5K |
| 83735 | <1% | 1,342 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 433 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 525 | $5K |
| 81003 | <1% | 3,319 | $5K | |
| 83690 | <1% | 1,374 | $4K | |
| 87275 | <1% | 418 | $4K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 72 | $4K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 67 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 273 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 664 | $3K |
| 83880 | <1% | 129 | $3K | |
| 83605 | <1% | 301 | $1K | |
| 84100 | <1% | 595 | $1K | |
| 81001 | <1% | 679 | $1K | |
| 85730 | <1% | 497 | $1K | |
| 85610 | <1% | 630 | $1K | |
| 80305 | <1% | 117 | $1K | |
| 82746 | <1% | 163 | $965.09 | |
| 82607 | <1% | 142 | $921.71 | |
| 82728 | <1% | 146 | $826.35 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 24 | $811.39 |
| 85379 | <1% | 192 | $788.98 | |
| 86140 | <1% | 226 | $782.80 | |
| 80076 | <1% | 158 | $752.93 | |
| 85027 | <1% | 182 | $734.93 | |
| 82150 | <1% | 219 | $614.41 | |
| 83550 | <1% | 125 | $496.85 | |
| 87040 | <1% | 105 | $479.68 | |
| 92551 | <1% | 45 | $478.12 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 145 | $415.99 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 13 | $392.92 |
| 82803 | <1% | 54 | $374.46 | |
| 83540 | <1% | 125 | $374.38 | |
| 81025 | <1% | 56 | $369.91 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 159 | $285.60 |
| 83655 | <1% | 12 | $157.80 | |
| 82550 | <1% | 34 | $76.25 | |
| 84703 | <1% | 12 | $75.20 | |
| 82553 | <1% | 33 | $71.35 | |
| 85652 | <1% | 44 | $66.04 | |
| 85014 | <1% | 12 | $30.84 | |
| 85018 | <1% | 12 | $30.84 | |
| 0011A | <1% | 18 | $23.04 | |
| 90677 | <1% | 12 | $0.05 | |
| 90686 | 0% | 201 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 45 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVANATOR, JONATHAN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Indiana University Health Fort Wayne Physicians, LLC | Muncie, IN | $1.63M |
| Indiana University Health Ball Memorial Hospital, INC. | Muncie, IN | $1.55M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.